BloggingStocks has a new home! Daily Finance.

Click here to visit the new home of BloggingStocks!

Hot on DailyFinance:

See More Stories

ClinicalStageBiotechnologyCompany posts

Feed

Options Update: Clinical biotechnology stocks volatility near average

Posted Aug 25th 2009 8:00AM by Paul Foster (RSS feed)
Filed under: Options

Theravance (NASDAQ: THRX) biotechnology company closed at $15.22. THRX September volatility is at 65, October is at 72, December is at 78 verses its 26-week average of 78 according to Track Data, suggesting decreasing near term price movement.

Seattle Genetics (NASDAQ: SGEN) a clinical stage biotechnology company, closed at $12.09. SGEN October and March 2010 option implied volatility of 60 is near its 26-week average according to Track Data, suggesting non-directional price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.

Symbol Lookup
IndexesChangePrice
DJIA-74.9212,454.83
NASDAQ-1.852,837.53
S&P 500-2.861,317.82

Last updated: May 26, 2012: 11:12 AM

Hot Stocks

General Electric

19.20-0.05(-0.26)

Alcoa

8.630.00(0.00)

Apple Inc

562.29-3.03(-0.54)

Google Inc 'A'

591.53-12.13(-2.01)

Bank of America

7.15+0.01(+0.14)

Wal-Mart Stores

65.31+0.24(+0.37)

Exxon Mobil Corp

82.08-0.53(-0.64)

Ford

10.60+0.01(+0.09)

Citigroup

26.47-0.19(-0.71)

IBM

194.30-1.79(-0.91)

Yahoo

15.36+0.01(+0.07)

Starbucks

54.56-0.20(-0.37)

Microsoft

29.06-0.01(-0.03)

Home Depot

49.44-0.27(-0.54)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

  • My Portfolio
  • Create a New Portfolio

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1338045178419 ms.